Plecanatide (Trulance)

FDA-approved product existsPeptideImmune & gut

Awaiting review, BioHarmony verdict

Not yet scored. Queued for review; until then rely on the status and sources below.

What is Plecanatide (Trulance)?

FDA-approved plecanatide is marketed as Trulance for chronic idiopathic constipation and irritable bowel syndrome with constipation in adults.

Saved on this device only.

Dosing as published

Source-reported figures only. This page does not calculate a personal dose.

Approved labelTRULANCE prescribing information for chronic idiopathic constipation and IBS-C
PopulationAdults covered by the approved TRULANCE indications
Dose3 mg
RouteOral tablet with or without food
FrequencyOnce daily
DurationLong-term use within the approved indication
PreparationReady-to-use 3 mg tablet; no reconstitution. The label permits crushing in applesauce or water and gives nasogastric or gastric feeding-tube instructions.
Source: Dosage and Administration sections 2.1-2.2; Dosage Forms and Strengths section 3

More reported protocols

Members

Members can compare additional reported doses, schedules, and preparation notes.

Trust & sourcing

  1. Last revieweddone
  2. Next reviewupcoming
US approvalFDA-approved product exists
CompoundingFDA-approved product exists; compounded copies are not FDA approved

Primary sources

The Ultimate Peptides Guide

Spot stronger candidates, weak evidence, and seller red flags before you buy.

Free. Includes evidence and regulatory updates. Unsubscribe anytime.